🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseMASH prevalence in GLP-1 users — November 2025 Page 6

MASH prevalence in GLP-1 users — November 2025

tampaLisa73 Wed, Jun 4, 2025 at 3:50 AM 44 replies 2,251 viewsPage 6 of 9
sean_dublin
Member
212
890
Nov 2024
Dublin, IE
Jun 9, 2025 at 11:45 AM#26
TrialTracker_MD said:
The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the…

I read this differently. The confidence in this thread is running ahead of the evidence, and I would rather the uncertainty were stated than smoothed over because it is unsatisfying.

35 8hannah_MT, Dr.SportsMedIN, amy_econ_NJ and 32 others
Reply Quote Save Share Report
Dr.EM_Chicago
Member
567
2,567
May 2024
Chicago, IL
Jun 9, 2025 at 10:09 PM#27
TrialTracker_MD said:
The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the…

True, with the qualification that this is a self-selected group. The people for whom it did not work post less, and that shapes everything we think we know.

36 9matt_MKE, Dr.ReproEndo, lucas_SP_BR and 33 others
Reply Quote Save Share Report
paul_denver
Member
723
3,234
May 2024
Denver, CO
Jun 10, 2025 at 8:32 AM#28
TrialTracker_MD said:
The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the…

Bookmarking. The distinction being drawn above is the one nobody else makes.

37 10wendy_avl, jason_paloalto, Dr.LeslieOBGYN and 34 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
jim_asheville
Member
289
1,234
Aug 2024
Asheville, NC
Jun 10, 2025 at 6:55 PM#29

From the other side of the consultation, briefly. Start from the measurement rather than the conclusion. Almost every disagreement here turns out to be two people measuring different things and comparing the numbers anyway.

38 11wanda_boise, NurseAsh_DET, BenResearch_OR and 35 others
Reply Quote Save Share Report
tampaLisa73
Member
312
1,456
Oct 2024
Tampa, FL
Jun 11, 2025 at 5:18 AM#30

Closing the loop on my own question.

Reporting back for the archive rather than for the thread: I did the narrow version of what was suggested, gave it the full interval, and it settled. Posting it because threads without a follow-up are half a thread.

10 8TomFromTexas, mike.trainer_LA, sarah_nash92 and 7 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register